Skin disease: a cardinal feature of systemic sclerosis
The DOI matches its Crossref record; 39 of the 42 references it cites were found in a registry or an index.
Abstract
Despite the heterogeneity of SSc, almost all patients have skin involvement. As such, skin manifestations are critical in the initial diagnosis of SSc and in the subsequent sub-classification into the different subsets of disease. The two principal subsets are lcSSc and dcSSc. The main difference between these two subsets is the speed of disease progression and the extent and severity of skin and visceral involvement; lcSSc has an insidious onset with skin involvement confined largely to the face and extremities. Whilst vascular manifestations of SSc such as pulmonary arterial hypertension are typically more common in lcSSc, patients in both subsets can develop ischaemic digital ulcers. In dcSSc, disease progression is very rapid, with skin thickening extending beyond the extremities and earlier, more widespread internal organ involvement. DcSSc is generally considered to be the more severe subset of the disease. Skin scores in SSc correlate inversely with survival and are considered a valuable marker of disease severity. Skin involvement is easily detectable and, using the modified Rodnan skin score, the degree of skin fibrosis can be quantified. As well as general management measures, a number of targeted therapies are commonly used for treatment of cutaneous manifestations of SSc. These include the intravenous prostanoid iloprost and the dual endothelin receptor antagonist bosentan, which is approved in Europe for the prevention of new digital ulcers.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In skin excessive matrix deposition increases stiffness, increases hardness, and leads to loss of cutaneous tissues like, fat tissue, sweat glands, hair follicles, and sebaceous glands (152).”
From Unraveling SSc Pathophysiology; The Myofibroblast (2018) · cites this paper as [152]
Citations
Cites
Preliminary criteria for the classification of systemic sclerosis (scleroderma)
Masi, A. T., & Subcommittee For Scleroderma Criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee (1980) · Arthritis & Rheumatism · doi:10.1002/art.1780230510 · Cited by 4,898
Scleroderma (systemic sclerosis): classification, subsets and pathogenesis
(2001) · Classic Papers in Rheumatology · doi:10.3109/9780203214237-95 · Cited by 3,950
Self-citationARTHRITIS AND ALLIED CONDITIONS
BERNARD I. COMROE, T. L., & HOLLANDER, J. L. (1949) · The American Journal of the Medical Sciences · doi:10.1097/00000441-194911000-00026 · Cited by 1,581
FERRI, C., VALENTINI, G., COZZI, F., SEBASTIANI, M., MICHELASSI, C., LA MONTAGNA, G., BULLO, A., CAZZATO, M., TIRRI, E., STORINO, F., et al. (2002) · Medicine · doi:10.1097/00005792-200203000-00004 · Cited by 764
Clements, P., Lachenbruch, P. A., Seibold, J. R., Zee, B. C.-Y., Steen, V. D., Brennan, P., Silman, A. J., Allegar, N. E., Varga, J., & Massa, M. C. (1993) · PubMed · Cited by 449
Following the Molecular Pathways toward an Understanding of the Pathogenesis of Systemic Sclerosis
Jimenez, S. A., & Derk, C. T. (2004) · Annals of Internal Medicine · doi:10.7326/0003-4819-140-1-200401060-00010 · Cited by 316
Hunzelmann, N., Genth, E., Krieg, T., Lehmacher, W., Melchers, I., Meurer, M., Moinzadeh, P., Muller-Ladner, U., Pfeiffer, C., Riemekasten, G., et al. (2008) · Rheumatology · doi:10.1093/rheumatology/ken179 · Cited by 287
Self-citationFürst, D. E., Clements, P. J., Steen, V. D., Medsger, T. A., Masi, A. T., D’Angelo, W., Lachenbruch, P. A., Grau, R. G., & Seibold, J. R. (1998) · PubMed · Cited by 277
Vancheeswaran, R., Magoulas, T., Efrat, G., Wheeler-Jones, C. P. D., Olsen, I., Penny, R., & Black, C. M. (1994) · PubMed · Cited by 239
Sato, S., Nagaoka, T., Hasegawa, M., Tamatani, T., Nakanishi, T., Takigawa, M., & Takehara, K. (2000) · PubMed · Cited by 233
Self-citation
Research works printed but not linked: 7
- Gintrac, 1847, Note sur la sclerodermie, Rev Med Chir Paris, 2, 263
- Korn, 2001, Pathogenesis of systemic sclerosis, 1643
- Ingraham, 2006, Morbidity of digital tip ulcerations in scleroderma, Arthritis Rheum, 54, F78
- Poormoghim, 2000, Systemic sclerosis sine scleroderma, Arthritis Rheum, 43, 444, 10.1002/1529-0131(200002)43:2<444::aid-anr27>3.0.co;2-g · doi:10.1002/1529-0131(200002)43:2<444::aid-anr27>3.0.co;2-g
- Steen, 2000, Severe organ involvement in systemic sclerosis with diffuse scleroderma, Arthritis Rheum, 11, 2437, 10.1002/1529-0131(200011)43:11<2437::aid-anr10>3.0.co;2-u · doi:10.1002/1529-0131(200011)43:11<2437::aid-anr10>3.0.co;2-u
- Clements, 2000, Skin thickness score as a predictor and correlate of outcome in systemic sclerosis, Arthritis Rheum, 43, 2445, 10.1002/1529-0131(200011)43:11<2445::aid-anr11>3.0.co;2-q · doi:10.1002/1529-0131(200011)43:11<2445::aid-anr11>3.0.co;2-q
- Steen, 2001, Improvement in skin thickening in systemic sclerosis associated with improved survival, Arthritis Rheum, 44, 2828, 10.1002/1529-0131(200112)44:12<2828::aid-art470>3.0.co;2-u · doi:10.1002/1529-0131(200112)44:12<2828::aid-art470>3.0.co;2-u
Cited by
Knobler, R., Moinzadeh, P., Hunzelmann, N., Kreuter, A., Cozzio, A., Mouthon, L., Cutolo, M., Rongioletti, F., Denton, C. P., Rudnicka, L., et al. (2017) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/jdv.14458 · Cited by 261
Self-citationCutaneous Manifestations of Scleroderma and Scleroderma-Like Disorders: a Comprehensive Review
Ferreli, C., Gasparini, G., Parodi, A., Cozzani, E., Rongioletti, F., & Atzori, L. (2017) · Clinical Reviews in Allergy & Immunology · doi:10.1007/s12016-017-8625-4 · Cited by 241
Unraveling SSc Pathophysiology; The Myofibroblast
van Caam, A., Vonk, M., van den Hoogen, F., van Lent, P., & van der Kraan, P. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.02452 · Cited by 153
“In skin excessive matrix deposition increases stiffness, increases hardness, and leads to loss of cutaneous tissues like, fat tissue, sweat glands, hair follicles, and sebaceous glands (152).”
BackgroundThe lens as a model for fibrotic disease
ELDRED, J., Dawes, L. J., & Wormstone, I. M. (2011) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.2010.0341 · Cited by 143
Ocular findings in patients with systemic sclerosis
Gomes, B. F., de Santhiago, M. R., Magalhães, P. D. A., Kara-Júnior, N., de Azevedo, M. N. L., & de Moraes, H. V. (2011) · Clinics · doi:10.1590/s1807-59322011000300003 · Cited by 102
“It is well known that the diffuse subtype is associated with a worse prognosis and an earlier disease onset.(10,18,19) However, our study found no significant association between the subsets of SSc and the presence of either KCS or retinal microvascular abnormalities.”
Metadata
- Authors
- Krieg, T., & Takehara, K.
- Affiliations
- Kanazawa University (JP)
- Venue
- Rheumatology
- Publisher
- Oxford University Press (OUP)
- Published
- 2006-06
- Volume
- 48
- Issue
- suppl_3
- Pages
- iii14-iii18
- ISSN
- 1462-0324 (ISSN-L)
- 1462-0332
- OpenAlex
- W2119959480
- Cited by
- 135
- References
- 42
- Citations by year
- 2026: 2 · 2024: 7 · 2023: 7 · 2022: 9 · 2021: 5 · 2020: 10 · 2019: 9 · 2018: 16 · 2017: 8 · 2016: 12 · 2015: 8 · 2014: 8 · 2013: 8 · 2012: 7
- FWCI
- 0.09
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Lara D. Veeken (publishedVersion)
- PubMed (publishedVersion)
- Funders
- University of Pittsburgh
- Actelion Pharmaceuticals
- Topics
- Health Sciences › Medicine › Rheumatology › Systemic Sclerosis and Related Diseases
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Pulmonary Hypertension Research and Treatments
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Connective tissue disorders research
- Keywords
- systemic sclerosis, skin involvement, limited cutaneous systemic sclerosis, diffuse cutaneous systemic sclerosis, skin thickening, modified Rodnan skin score, skin score, disease severity, pulmonary arterial hypertension, iloprost, bosentan, endothelin receptor antagonists, prostanoids, cutaneous manifestations
- MeSH terms
- Collagen, Diagnosis, Differential, Fibrosis, Humans, Scleroderma, Systemic, Skin, Skin Ulcer, Transforming Growth Factor beta, Connective Tissue Growth Factor
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Skin disease: a cardinal feature of systemic sclerosis. https://app.cochat.ai/papers/10.1093/rheumatology/kep108
- The paper
- Krieg, T., & Takehara, K. (2006). Skin disease: a cardinal feature of systemic sclerosis. Rheumatology. https://doi.org/10.1093/rheumatology/kep108
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.